Cargando…
Exploring the Interplay of Telomerase Reverse Transcriptase and β-Catenin in Hepatocellular Carcinoma
SIMPLE SUMMARY: Liver cancer is one of the deadliest human cancers. Two of the most common molecular aberrations in liver cancer are: (1) activating mutations in the gene encoding β-catenin (CTNNB1); and (2) promoter mutations in telomerase reverse transcriptase (TERT). Here, we review recent findin...
Autores principales: | Kotiyal, Srishti, Evason, Kimberley Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8393605/ https://www.ncbi.nlm.nih.gov/pubmed/34439356 http://dx.doi.org/10.3390/cancers13164202 |
Ejemplares similares
-
Heterogeneous beta-catenin activation is sufficient to cause hepatocellular carcinoma in zebrafish
por: Kalasekar, Sharanya M., et al.
Publicado: (2019) -
Expression of telomerase-associated protein 1 and telomerase reverse transcriptase in hepatocellular carcinoma
por: Toshikuni, N, et al.
Publicado: (2000) -
Clinical Significance of Telomerase Reverse-Transcriptase Promoter Mutations in Hepatocellular Carcinoma
por: Pezzuto, Francesca, et al.
Publicado: (2021) -
Telomerase reverse transcriptase moonlights: Therapeutic targets beyond telomerase
por: Maida, Yoshiko, et al.
Publicado: (2015) -
Hepatitis B Virus–Telomerase Reverse Transcriptase Promoter Integration Harnesses Host ELF4, Resulting in Telomerase Reverse Transcriptase Gene Transcription in Hepatocellular Carcinoma
por: Sze, Karen Man‐Fong, et al.
Publicado: (2020)